Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
G M Mead, M R Sydes, J Walewski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2006
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
M S Aapro, D A Cameron, R Pettengell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2010
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M S Aapro, J Bohlius, D A Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
M Ghielmini, U Vitolo, E Kimby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2025
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T A Eyre, K Cwynarski, F d'Amore, et al.
Bone Marrow Transplantation
|
April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy
J Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study
J Walewski, E Kraszewska, O Mioduszewska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2013
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network
C Y Cheah, A George, E Giné, et al.
Leukemia
|
November 25, 2015
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials
E Hoster, C H Geisler, J Doorduijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
J Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
G M Mead, M R Sydes, J Walewski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2006
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
M S Aapro, D A Cameron, R Pettengell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2010
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M S Aapro, J Bohlius, D A Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
M Ghielmini, U Vitolo, E Kimby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2025
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T A Eyre, K Cwynarski, F d'Amore, et al.
Bone Marrow Transplantation
|
April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy
J Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study
J Walewski, E Kraszewska, O Mioduszewska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2013
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network
C Y Cheah, A George, E Giné, et al.
Leukemia
|
November 25, 2015
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials
E Hoster, C H Geisler, J Doorduijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
J Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Page
of 5